|
Volumn 53, Issue 5, 1998, Pages 298-304
|
Risks, benefits and costs of HRT in menopausal women;Risques, benefices et couts du traitement hormonal substitutif la menopause
a |
Author keywords
Benefit risk balance; Cost effectiveness analysis; Hormone replacement therapy
|
Indexed keywords
ARTICLE;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
MENOPAUSE;
RISK BENEFIT ANALYSIS;
AGED;
BIOLOGICAL MODEL;
BREAST TUMOR;
CEREBROVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
COHORT ANALYSIS;
COMPARATIVE STUDY;
COMPUTER SIMULATION;
COST;
DRUG COST;
DRUG EFFECT;
DRUG MONITORING;
ECONOMICS;
ENDOMETRIUM TUMOR;
ESTROGEN THERAPY;
HEART DISEASE;
HYSTERECTOMY;
LIFE EXPECTANCY;
MIDDLE AGED;
PATIENT COMPLIANCE;
PHARMACOECONOMICS;
POSTMENOPAUSE OSTEOPOROSIS;
QUALITY ADJUSTED LIFE YEAR;
RISK ASSESSMENT;
ESTROGEN;
GESTAGEN;
AGED;
AGED, 80 AND OVER;
BREAST NEOPLASMS;
CEREBROVASCULAR DISORDERS;
COHORT STUDIES;
COMPUTER SIMULATION;
COST-BENEFIT ANALYSIS;
COSTS AND COST ANALYSIS;
DRUG COSTS;
DRUG MONITORING;
ECONOMICS, PHARMACEUTICAL;
ENDOMETRIAL NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HEART DISEASES;
HUMANS;
HYSTERECTOMY;
LIFE EXPECTANCY;
MENOPAUSE;
MIDDLE AGED;
MODELS, BIOLOGICAL;
OSTEOPOROSIS, POSTMENOPAUSAL;
PATIENT COMPLIANCE;
PROGESTINS;
QUALITY-ADJUSTED LIFE YEARS;
RISK ASSESSMENT;
|
EID: 0031875519
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (19)
|